Huons Meditech Wins Trademark Lawsuit Against Chinese Counterfeiters of DermaShine

Huons Meditech has established a legal basis to protect its brand value in the Chinese market and to prevent consumer damage caused by counterfeit products.

On July 29, Huons Meditech, the medical device specialist of Huons Group, announced that it achieved a final victory in a lawsuit against a local company for infringing the trademark rights of its flagship ‘DermaShine’ series.

Previously, Huons Meditech discovered that Hebei Feiza Precision Equipment Co., Ltd. in China was illegally using the 'DermaShine' trademark for counterfeit sales by unauthorized use of the names 'DermaShine' and 'DermaShine Max.' In response, the company filed a trademark infringement lawsuit with the Anci District People's Court in Langfang City, China, on July 1 last year, taking resolute action.

Subsequently, on June 18, the Anci District People's Court in Langfang City ruled in favor of Huons Meditech and delivered a verdict for the plaintiff. As the defendant did not appeal within the one-month appeal window, the ruling became legally binding as of July 18.

According to the court's ruling, the defendant (Hebei Feiza Precision Equipment Co., Ltd.) must immediately cease all acts infringing the plaintiff’s (Huons Meditech’s) trademark rights and must also halt use of any trademarks that are identical or similar to the plaintiff’s registered marks. In addition, the defendant is ordered to destroy all infringing products in distribution—including all display shelves and packaging boxes—and to delete and discard all promotional materials containing information on the infringing products. The court further ordered the defendant to compensate the plaintiff for reasonable legal expenses incurred in protecting its rights within ten days from the effective date of the ruling.

Huons Meditech is aware that, apart from this company, numerous other counterfeit ‘DermaShine’ and ‘Multi Needle’ products are in distribution, and it plans to proceed with additional legal action to address these violations. Taking this decision as a turning point, the company intends to restore market order and increase its market share in China, leveraging its technical prowess and genuine ‘DermaShine’ brand.

Changwoo Ha, CEO of Huons Meditech, stated, “This legal victory is a meaningful result, as it demonstrates the recognition of the unique intellectual property rights and value of the ‘DermaShine’ brand by the Chinese courts. We will continue to respond strictly to all illegal acts of technology and brand infringement, in order to ensure that customers around the world can confidently use genuine DermaShine products, and we will spare no effort to protect our intellectual property rights.”

This content was produced with the assistance of AI translation services.